{
    "root": "34142fb7-c35a-7a27-e063-6394a90abd82",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Clonazepam",
    "value": "20250501",
    "ingredients": [
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "CLONAZEPAM",
            "code": "5PE9FDE8GB"
        }
    ],
    "indications": null,
    "contraindications": "Clonazepam is available as a tablet. The tablets should be administered with water by swallowing the tablet whole.",
    "warningsAndPrecautions": "Clonazepam tablets USP 2 mg are white to off white, round, flat faced, beveled edge tablets debossed with “C 2” on one side and plain on the other. They are supplied as follows:\n                  NDC: 70518-2232-00\n                  NDC: 70518-2232-01\n                  PACKAGING: 100 in 1 BOX\n                  PACKAGING: 1 in 1 POUCH\n                  \n                  Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature].\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions": "Clonazepam tablets are contraindicated in patients with the following conditions:\n                  \n                     History of sensitivity to benzodiazepines\n                     Clinical or biochemical evidence of significant liver disease\n                     Acute narrow angle glaucoma (it may be used in patients with open angle glaucoma who are receiving appropriate therapy)."
}